| Mr Michael Allen Page, MD | |
|
1955 Nw Northrup St, Portland, OR 97209-1614 | |
| (503) 227-2020 | |
| Not Available |
| Full Name | Mr Michael Allen Page |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 18 Years |
| Location | 1955 Nw Northrup St, Portland, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144491523 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | MD192779 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Health Northwest Pc | 9234039926 | 57 |
News Archive
Survivors of adolescent and young adult cancer often have stronger social networks than their non-cancer peers, according to St. Jude Children's Research Hospital researchers, who hope to translate that support into better lives for the nation's growing population of cancer survivors.
Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy.
New preclinical findings from extensive cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with some mitochondrial disorders-complex conditions with severe energy deficiency for which no proven effective treatments exist.
EMBL researchers have designed a computational method to jointly analyze multiple types of molecular data from patients in order to identify molecular signatures that distinguish individuals.
› Verified 9 days ago
| Entity Name | Eye Health Northwest Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619959731 PECOS PAC ID: 9234039926 Enrollment ID: O20040109000739 |
News Archive
Survivors of adolescent and young adult cancer often have stronger social networks than their non-cancer peers, according to St. Jude Children's Research Hospital researchers, who hope to translate that support into better lives for the nation's growing population of cancer survivors.
Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy.
New preclinical findings from extensive cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with some mitochondrial disorders-complex conditions with severe energy deficiency for which no proven effective treatments exist.
EMBL researchers have designed a computational method to jointly analyze multiple types of molecular data from patients in order to identify molecular signatures that distinguish individuals.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Michael Allen Page, MD 1955 Nw Northrup St, Portland, OR 97209-1614 Ph: (503) 227-2020 | Mr Michael Allen Page, MD 1955 Nw Northrup St, Portland, OR 97209-1614 Ph: (503) 227-2020 |
News Archive
Survivors of adolescent and young adult cancer often have stronger social networks than their non-cancer peers, according to St. Jude Children's Research Hospital researchers, who hope to translate that support into better lives for the nation's growing population of cancer survivors.
Researchers have identified several target molecules which are suitable for the development of new allergy drugs. The Journal of Allergy and Clinical Immunology, the most prestigious journal in the field of allergology, has recently published an extensive review article on the prospects of drug therapy for allergy.
New preclinical findings from extensive cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with some mitochondrial disorders-complex conditions with severe energy deficiency for which no proven effective treatments exist.
EMBL researchers have designed a computational method to jointly analyze multiple types of molecular data from patients in order to identify molecular signatures that distinguish individuals.
› Verified 9 days ago
Amy Ying Tong, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1955 Nw Northrup St, Portland, OR 97209 Phone: 503-227-2020 | |
Sungjae Yang, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3375 Sw Terwilliger Bld, Casey Eye Institue, Portland, OR 97239 Phone: 503-494-5023 | |
Dr. Michael David Straiko, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1040 Nw 22nd Ave., Suite 200, Portland, OR 97210 Phone: 503-413-8202 Fax: 503-413-6937 | |
Allison Rebecca Loh, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 3375 Sw Terwilliger Blvd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
John Carl Morrison, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3303 Sw Bond Ave, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-418-0843 | |
Adam Marcus Hanif, Ophthalmology Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-3000 Fax: 503-494-4286 | |
Mr. John Jah-hyun Koo, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3600 N. Interstate Avenue, Department Of Opthalmology, Portland, OR 97227 Phone: 503-331-6330 Fax: 503-571-5877 |